Literature DB >> 7387019

Cimetidine-resistant gastric acid secretion in humans.

B Kisloff.   

Abstract

A 63-year-old white man presented with highly aggressive peptic ulcer disease that was nongastrinoma in cause. Intensive medical therapy, which included intravenous cimetidine, failed to ameliorate the course of the disease. The patient's gastric acid output was entirely uninfluenced by cimetidine administration with demonstrably adequate blood levels of the drug. This is the first reported case of gastric acid secretion resistant to an H-2 receptor antagonist in a clinical, rather than experimental, setting. Other instances of resistance to the acid-reducing properties of this class of drugs may account for some of the treatment failures encountered in clinical trials.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7387019     DOI: 10.7326/0003-4819-92-6-791

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  2 in total

1.  The refractory ulcer.

Authors:  D W Piper
Journal:  World J Surg       Date:  1987-06       Impact factor: 3.352

2.  Correlation between basal acid output and daily ranitidine dose required for therapy in Barrett's esophagus.

Authors:  M J Collen; D A Johnson
Journal:  Dig Dis Sci       Date:  1992-04       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.